Any Comments on this:
Click on the following hyperlink to view this filing: freeedgar.com ADVANCED VIRAL RESEARCH CORP
Filing Type: POS AM Description: Post-Effective Amendment Filing Date: Sep 25, 2000 Period End: N/A
Primary Exchange: Over the Counter Includes OTC and OTCBB Ticker: ADVR 5 RECENT DEVELOPMENTS
On September 18, 2000, we signed a private equity line of credit agreement with Spinneret Financial Systems, Inc. for the future issuance and purchase of shares of our common stock. The private equity line of credit agreement establishes what is sometimes termed an equity line of credit or an equity drawdown facility. Spinneret has committed up to $20 million to purchase shares of our common stock. Beginning on the date that a registration statement covering the resale of the shares issuable pursuant to the equity line of credit is declared effective by the Commission, and continuing for thirty (30) months thereafter, we may, from time to time, in our sole discretion, sell or "put" shares of our common stock to Spinneret at a price equal to the market price of the common stock. Spinneret's obligation to purchase the shares of our common stock is subject to the satisfaction of the conditions included on page 31 of this prospectus. Once every fifteen (15) trading days, we may request an advance the maximum amount of which is dependent among other things, on the trading volume of our common stock. The number of shares that we will issue to Spinneret in return for the advance will be determined by dividing the amount of the advance by the average of the three lowest reported closing bid prices of our common stock over a 25 trading day period ending on the advance notice date, as set forth in private equity line of credit agreement.
We will receive the amount of the advance less any escrow agent fees and a five percent (5%) cash placement fee payable to the placement agent, May Davis Group, Inc., which introduced Spinneret to us. May Davis is not obligated to purchase any of our shares, but as an additional placement fee, we have issued to May Davis a Class A Warrant to purchase 5,000,000 shares of our common stock at an exercise price per share equal to $1.00, exercisable in part or in whole at any time by May Davis at its discretion until September 18, 2005, and a Class B Warrant to purchase 5,000,000 shares of our common stock at an exercise price equal to the greater of $1.00 or 110% of the bid price of the common stock on the applicable advance date, exercisable pro rata on the basis of the number of shares of common stock issuable on each advance date for a period of sixty months from the date of issuance. We may redeem the warrants at a redemption price of $.01 per share provided that the bid price for our common stock equals at least $4.00 per share for a period of ten (10) consecutive trading days, as described therein. May Davis is also entitled to certain "piggyback" registration rights with respect to the shares of common stock issuable upon exercise of the warrants pursuant to a registration rights agreement.
In addition, pursuant to the equity line of credit agreement, each officer, director and affiliate of Advanced Viral has agreed that he, she or it will not, directly or indirectly, without the prior written consent of Spinneret, issue, offer, agree or offer to sell, sell, grant an option for the purchase or sale of, transfer, pledge, assign, hypothecate, distribute or otherwise encumber or dispose of (whether pursuant to Rule 144 promulgated under the Securities Act of 1933, as amended, or otherwise) any shares of our common stock, including options, rights, warrants or other securities underlying, convertible into, exchangeable or exercisable for or evidencing any right to purchase or subscribe for any shares of our common stock (whether or not beneficially owned by the undersigned), or any beneficial interest therein for a period of ten (10) trading days following the receipt of an advance notice by Advanced Viral pursuant to the agreement. |